EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Genetic Spectrum of Nine Cases of NLRP3‐Associated Autoinflammatory Disease (NLRP3‐AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses

Yaoyao Shangguan iD, Xingru Ding iD, Le Ma iD, Yi-Xin Cai iD, Shulei Xiang iD, Xiu-Feng Huang iD, Yunyan Shen iD, Hai-Guo Yu iD, Wenjie Zheng iD

Journal of Immunology Research · 2024

DOI: 10.1155/2024/5722548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2024. Verfasst von Yaoyao Shangguan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Rheumatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang,…. Hauptthemen laut MEDLINE: Cryopyrin-Associated Periodic Syndromes, Biological Products. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Medical Science and Technology Project of Zhejiang Province, Wenzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

NLRP3‐associated autoinflammatory disease (NLRP3‐AID) is characterized by gain‐of‐function variants in the NLRP3 gene. Since there are little literature focusing on pediatric NLRP3‐AID in China, we aimed to elucidate the phenotypic and genotypic profiles of Chinese patients with NLRP3‐AID.

Methods

Patients with NLRP3‐AID at three rheumatology centers in China were genotyped through whole exome sequencing or gene panel sequencing. Sanger sequencing was performed on all patients and their parents. Clinical phenotype, treatment, and prognosis were analyzed.

Results

Nine patients with NLRP3‐AID were enrolled between December 2014 and October 2022 with an average follow‐up period exceeding 30 months. The median age of onset was 12 months, and 66.7% were younger than 3 years old. The diagnosis was significantly delayed and the median delay duration was 115 months. The patients most commonly presented with rash (100%), arthritis/arthralgia (88.9%), lymphadenopathy (88.9%), fever (77.8%), and growth retardation (44.4%). During acute attack, white blood cell, C‐reactive protein, and/or erythrocyte sedimentation rate all increased in all cases, and inflammatory markers remained elevated beyond 7 days postfever resolution in 57.1% of patients (4/7). Two cases of chronic infantile neurological cutaneous articular syndrome (CINCA) had clubbed fingers, one with interstitial lung disease, a finding rarely reported. Treatment with glucocorticoids (77.8%) and biologic agents (33.3%) yielded 66% complete remission and 33% partial remission. Genetic analysis identified eight pathogenic NLRP3 missense mutations, including one novel mutation.

Conclusions

Our study illuminated the distinct clinical and genetic features of Chinese NLRP3‐AID patients, emphasizing the significance of early genetic screening. Despite delayed diagnosis, treatment primarily with glucocorticoids and biologic agents, led to favorable outcomes. Genetic heterogeneity, including a novel mutation, highlighted the complexity of NLRP3‐AID in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryopyrin-Associated Periodic SyndromesBiological ProductsChildHumansInfantNLR Family, Pyrin Domain-Containing 3 ProteinMutationGenetic Variation

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinBiological Products

Autor:innen und Institutionen

  • Department of Pediatric Rheumatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Structural Malformations in Children of Zhejiang Province, Wenzhou, Zhejiang, China.
  • Zhejiang Provincial Clinical Research Center for Pediatric Disease, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Rheumatology and Immunology Department, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Nephrology and Immunology, Children's Hospital of Soochow University, Suzhou, China.

ORCID-Profile: Yaoyao Shangguan, Xingru Ding, Le Ma, Yi-Xin Cai, Shulei Xiang, Xiu-Feng Huang, Yunyan Shen, Hai-Guo Yu, Wenjie Zheng

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Medical Science and Technology Project of Zhejiang Province
  • Wenzhou Medical University

Zitieren

APA

Shangguan, Y., Ding, X., Ma, L., Cai, Y. X., Xiang, S., Huang, X. F., Shen, Y., Yu, H. G., & Zheng, W. (2024). Clinical and Genetic Spectrum of Nine Cases of NLRP3‐Associated Autoinflammatory Disease (NLRP3‐AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses. Journal of Immunology Research. https://doi.org/10.1155/2024/5722548

Vancouver

Shangguan Y, Ding X, Ma L, Cai YX, Xiang S, Huang XF, et al. Clinical and Genetic Spectrum of Nine Cases of NLRP3‐Associated Autoinflammatory Disease (NLRP3‐AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses. Journal of Immunology Research. 2024. doi:10.1155/2024/5722548

BibTeX
@article{Shangguan2024,
  author = {Shangguan, Yaoyao and Ding, Xingru and Ma, Le and Cai, Yi-Xin and Xiang, Shulei and Huang, Xiu-Feng and Shen, Yunyan and Yu, Hai-Guo and Zheng, Wenjie},
  title = {Clinical and Genetic Spectrum of Nine Cases of NLRP3‐Associated Autoinflammatory Disease (NLRP3‐AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses},
  journal = {Journal of Immunology Research},
  year = {2024},
  doi = {10.1155/2024/5722548}
}
Kostenlos starten →